- Home
- NNNN vs VICR Comparison
NNNN vs VICR Comparison
Compare NNNN & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- VICR
- Stock Information
- Founded
- NNNN 2021
- VICR 1981
- Country
- NNNN Germany
- VICR United States
- Employees
- NNNN N/A
- VICR N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VICR Industrial Machinery/Components
- Sector
- NNNN Health Care
- VICR Technology
- Exchange
- NNNN Nasdaq
- VICR Nasdaq
- Market Cap
- NNNN 2.2B
- VICR 2.3B
- IPO Year
- NNNN 2025
- VICR N/A
- Fundamental
- Price
- NNNN $28.10
- VICR $51.93
- Analyst Decision
- NNNN
- VICR Hold
- Analyst Count
- NNNN 0
- VICR 2
- Target Price
- NNNN N/A
- VICR $43.00
- AVG Volume (30 Days)
- NNNN 82.0K
- VICR 282.0K
- Earning Date
- NNNN 10-23-2025
- VICR 10-21-2025
- Dividend Yield
- NNNN N/A
- VICR N/A
- EPS Growth
- NNNN N/A
- VICR 576.06
- EPS
- NNNN 0.06
- VICR 1.45
- Revenue
- NNNN $8,185,146.00
- VICR $379,346,000.00
- Revenue This Year
- NNNN N/A
- VICR $20.25
- Revenue Next Year
- NNNN N/A
- VICR $4.82
- P/E Ratio
- NNNN $566.20
- VICR $35.08
- Revenue Growth
- NNNN 21.95
- VICR 2.46
- 52 Week Low
- NNNN $5.18
- VICR $38.93
- 52 Week High
- NNNN $55.65
- VICR $65.70
- Technical
- Relative Strength Index (RSI)
- NNNN 38.40
- VICR 56.06
- Support Level
- NNNN $28.13
- VICR $48.63
- Resistance Level
- NNNN $33.32
- VICR $50.17
- Average True Range (ATR)
- NNNN 5.89
- VICR 1.93
- MACD
- NNNN -0.54
- VICR -0.12
- Stochastic Oscillator
- NNNN 26.27
- VICR 55.20
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.